With COVID-19 cases flooding emergency rooms and deaths on the rise among the unvaccinated, Northeastern researchers wanted to know why a sizable portion of the United States remained weary of or flat-out opposed to vaccines.
Sep 16, 2021
0
139
With less than half the United States population fully vaccinated for COVID-19 and as the delta variant sweeps the nation, the U.S. surgeon general issued an advisory that called misinformation an urgent threat to public ...
Jul 29, 2021
0
67
Companies selling snacks and fast food leveraged Aotearoa's first pandemic lockdown to market their unhealthy products to New Zealanders, a University of Auckland study shows.
Mar 8, 2021
0
3
Social media platforms and those spreading deliberate vaccine misinformation should be held accountable and potentially face criminal sanctions, says Professor Melinda Mills, Director of the Leverhulme Centre for Demographic ...
Feb 18, 2021
0
2
Concern is growing about the spread of false information about vaccines. But should we consider criminalising people who deliberately spread false information—or could this do more harm than good? Two experts debate the ...
Feb 17, 2021
0
2
Now that a COVID-19 vaccine has arrived, many of us are eagerly awaiting the day we get our first shot. However, figuring out when you're eligible, and where to get vaccinated once you are, is challenging. The rules and registration ...
Jan 28, 2021
0
1
There has been a lot of news coverage about the COVID-19 vaccines recently developed and now being administered across the U.S.
Dec 21, 2020
0
5
A new poll conducted by the Jubilee Centre for Character and Virtues at the University of Birmingham has found that over 70% of parents worry about the risks as well as the physical and mental health implications of their ...
Dec 3, 2020
0
2
Let's talk breasts. It's a topic Dr. Amy Patel spends a lot of time discussing in a never-ending quest to dispel the myths women believe about breast cancer.
Oct 26, 2020
0
4
Shares of German biotech company CureVac, which is developing a leading coronavirus vaccine candidate, rocketed Friday in its first day of trading in New York after raising more than $200 million in an initial public offering.
Aug 15, 2020
0
4
